Yellow Fever Vaccines
Live-attenuated 17D strain vaccines for yellow fever prevention
This page catalogs 2 yellow fever vaccine products based on Max Theiler's 17D strain, developed in 1937. Theiler received the 1951 Nobel Prize in Physiology or Medicine for this work. The 17D strain remains one of the most successful vaccine strains in history, with the same attenuated lineage used in production for nearly 90 years.
Last updated: April 2026.
Yellow Fever Vaccine Catalog
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| YF-Vax | Yellow fever vaccine (17D-204) | Sanofi Pasteur | Live-attenuated viral | FDA Licensed | Only US-licensed yellow fever vaccine |
| Stamaril | Yellow fever vaccine (17D-204) | Sanofi Pasteur | Live-attenuated viral | Licensed (non-US) | International yellow fever vaccine |
Sources
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026) and EMA Medicines database. Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.